Key result
Anemia is highly prevalent in chronic heart failure, ranging from 4% to 23% in ambulatory populations to 30% to 61% in those with comorbid kidney disease, advanced age, or severe symptoms.
Population
Patients with chronic heart failure (CHF), including those with preserved ejection fraction
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May prompt anemia evaluation in chronic HF; leaves open whether correction improves outcomes.
Structured PICO
P
Population
Patients with chronic heart failure (CHF), including those with preserved ejection fraction
I
Intervention
Erythropoietic agents (discussed as potential therapy)
Anemia is highly prevalent in patients with chronic heart failure, particularly those with advanced age, kidney disease, and severe symptoms, and represents a potential therapeutic target.
Limitations
- Variability in estimated prevalence is partly attributable to use of inconsistent definitions of anemia in individual reports
Cite This Study
Tang et al. (2006) conducted a review in Chronic heart failure. Anemia is highly prevalent in chronic heart failure, ranging from 4% to 23% in ambulatory populations to 30% to 61% in those with comorbid kidney disease, advanced age, or severe symptoms.